Heart procedure may offer lasting migraine relief, new study hopes to prove

NCT ID NCT07629635

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This study looks at people with migraines who also have a small hole in the heart (PFO). Participants first take a blood-thinning drug (prasugrel) to see if their migraines improve. Those who respond are randomly assigned to either continue the drug alone or have a procedure to close the hole plus the drug. After stopping the drug, researchers check if the closure group has fewer migraines. The goal is to find a lasting treatment for migraine sufferers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Columbia University Irving Medical Center - NewYork Presbyterian Hospital (CUIMC/NYP)

    New York, New York, 10032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.